An event of endocarditis, stenosis, and aortic regurgitation was reported.A more comprehensive assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
|
It was reported that on (b)(6) 2011, a 25mm sjm trifecta valve was implanted.On (b)(6) 2019, structural valve deterioration was noted while hospitalized.The patient was hospitalized for left sided weakness which was due to large right side central nervous system (cns) lesion.The hospitalization was prolonged due to progressive neurological deficits and nosocomial infection with enterococcus fascism in blood due to the cns lesion that was complicated by endocarditis.The patient was prescribed antibiotics and methylprednisolone.An echocardiogram was performed on (b)(6) 2019, that noted moderate to severe mitral regurgitation (mr), mild tricuspid regurgitation (tr), the aortic valve was seated well however hemodynamic parameters suggest possible dysfunction/stenosis and moderate to severe aortic regurgitation (ar) was noted.While hospitalized the patient expired on (b)(6) 2019.The primary cause of the patient's death was due to a brain tumor.There was a possibility the valve contributed to the patient's death due to the reported endocarditis, therefore this event is being conservatively reported.
|